Sequential therapy with Vinorelbine followed by Gemcitabine in patients with metastatic non small cell lung cancer (NSCLC), performance status (PS) 2, or elderly with comorbidities-a multicenter phase II trial

This sequential treatment offers excellent palliative treatment with minimal toxicity for high-risk patients with metastatic NSCLC.